Download PDF
Am J Perinatol 2014; 31(S 01): S19-S24
DOI: 10.1055/s-0034-1378143
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Fetoscopic Laser Therapy for Twin–Twin Transfusion Syndrome: Beyond Current Gestational Age Limits

David Baud
1   Fetal Medicine Unit, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
2   Swiss Laser Group, University Hospitals of Lausanne and Inselspital-Bern, Switzerland
,
Rory Windrim
1   Fetal Medicine Unit, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
,
Johannes Keunen
1   Fetal Medicine Unit, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
,
Greg Ryan
1   Fetal Medicine Unit, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
› Author Affiliations
Further Information

Publication History

09 January 2014

18 April 2014

Publication Date:
24 June 2014 (online)

    Permissions and Reprints

Abstract

Both “early” (< 16 weeks' gestation) and “late” (> 26 weeks' gestation) presentations of twin–twin transfusion syndrome (TTTS) are rare and challenging complications of monochorionic/diamniotic twin pregnancies. Growing evidence suggests that fetoscopic laser therapy for both “early” and “late” TTTS is feasible, safe, and yields similar outcomes to cases treated between 16 and 26 weeks' gestation. We suggest reevaluation of conventional gestational age guidelines for laser therapy for TTTS.

Keywords

laser therapy - fetoscopy - monochorionic twins - neonatal mortality - twin–twin transfusion syndrome

Presentation Information

This work was presented at (1) TTTS Workshop 2013, Houston, Texas, June 2013 (oral); (2) 11th World Congress in Fetal Medicine, June 24, 2012, to June 28, 2012, Kos, Greece (oral); (3) 22nd International Society of Ultrasound in Obstetrics and Gynecology (ISUOG), September 9, 2012, to September 12, 2012, Copenhagen, Denmark (poster).


Article Condensation


Perinatal outcome following fetoscopic laser therapy for severe TTTS outside the “conventional” 16 to 26 week' GA range is associated with a comparable perinatal outcome.


 

  • References

  • 1 van Mieghem T, Baud D, Devlieger R , et al. Minimally invasive fetal therapy. Best Pract Res Clin Obstet Gynaecol 2012; 26 (5) 711-725
    CrossrefPubMedGoogle Scholar
  • 2 Simpson LL ; Society for Maternal-Fetal Medicine. Twin-twin transfusion syndrome. Am J Obstet Gynecol 2013; 208 (1) 3-18
    CrossrefPubMedGoogle Scholar
  • 3 van Klink JM, Koopman HM, van Zwet EW, Oepkes D, Walther FJ, Lopriore E. Cerebral injury and neurodevelopmental impairment after amnioreduction versus laser surgery in twin-twin transfusion syndrome: a systematic review and meta-analysis. Fetal Diagn Ther 2013; 33 (2) 81-89
    CrossrefPubMedGoogle Scholar
  • 4 Lopriore E, Oepkes D, Walther FJ. Neonatal morbidity in twin-twin transfusion syndrome. Early Hum Dev 2011; 87 (9) 595-599
    CrossrefPubMedGoogle Scholar
  • 5 Mosquera C, Miller RS, Simpson LL. Twin-twin transfusion syndrome. Semin Perinatol 2012; 36 (3) 182-189
    CrossrefPubMedGoogle Scholar
  • 6 Senat MV, Deprest J, Boulvain M, Paupe A, Winer N, Ville Y. Endoscopic laser surgery versus serial amnioreduction for severe twin-to-twin transfusion syndrome. N Engl J Med 2004; 351 (2) 136-144
    CrossrefPubMedGoogle Scholar
  • 7 Crombleholme TM, Shera D, Lee H , et al. A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2007; 197 (4) e1 –e9
    PubMedGoogle Scholar
  • 8 Devices M . Humanitarian Device Exemption. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/HumanitarianDeviceExemption/default.htm . US Food and Drug Administration (FDA) 2010. Last accessed on: May 17, 2014
    PubMed
  • 9 Devices M. Karl Storz Rigid TTTS Fetoscopy Instrument Set - H040005. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/Recently-ApprovedDevices/ucm078275.htm . US Food and Drug Administration (FDA) 2009. Last accessed on: May 17, 2014
    PubMedGoogle Scholar
  • 10 Dekoninck P, Deprest J, Lewi P , et al. Gestational age-specific reference ranges for amniotic fluid assessment in monochorionic diamniotic twin pregnancies. Ultrasound Obstet Gynecol 2013; 41 (6) 649-652
    CrossrefPubMedGoogle Scholar
  • 11 Ulm B, Ulm MR, Bernaschek G. Unfused amnion and chorion after 14 weeks of gestation: associated fetal structural and chromosomal abnormalities. Ultrasound Obstet Gynecol 1999; 13 (6) 392-395
    CrossrefPubMedGoogle Scholar
  • 12 Chmait RH, Korst LM, Llanes A, Mullin P, Lee RH, Ouzounian JG. Perioperative characteristics associated with preterm birth in twin-twin transfusion syndrome treated by laser surgery. Am J Obstet Gynecol 2013; 209 (3) e1-e8
    PubMedGoogle Scholar
  • 13 Salomon LJ, Ortqvist L, Aegerter P , et al. Long-term developmental follow-up of infants who participated in a randomized clinical trial of amniocentesis vs laser photocoagulation for the treatment of twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2010; 203 (5) e1-e7
    CrossrefPubMedGoogle Scholar
  • 14 van Klink JM, Koopman HM, Oepkes D, Walther FJ, Lopriore E. Long-term neurodevelopmental outcome in monochorionic twins after fetal therapy. Early Hum Dev 2011; 87 (9) 601-606
    CrossrefPubMedGoogle Scholar
  • 15 Lopriore E, Ortibus E, Acosta-Rojas R , et al. Risk factors for neurodevelopment impairment in twin-twin transfusion syndrome treated with fetoscopic laser surgery. Obstet Gynecol 2009; 113 (2 Pt 1) 361-366
    CrossrefPubMedGoogle Scholar
  • 16 Middeldorp JM, Sueters M, Lopriore E , et al. Fetoscopic laser surgery in 100 pregnancies with severe twin-to-twin transfusion syndrome in the Netherlands. Fetal Diagn Ther 2007; 22 (3) 190-194
    CrossrefPubMedGoogle Scholar
  • 17 Lopriore E, van Wezel-Meijler G, Middeldorp JM, Sueters M, Vandenbussche FP, Walther FJ. Neurodevelopmental outcome after laser therapy for twin-twin transfusion syndrome. Am J Obstet Gynecol 2007; 196 (1) e20 , author reply e20–e21
    CrossrefPubMedGoogle Scholar
  • 18 Baud D, Windrim R, Keunen J , et al. Fetoscopic laser therapy for twin-twin transfusion syndrome before 17 and after 26 weeks' gestation. Am J Obstet Gynecol 2013; 208 (3) e1-e7
    PubMedGoogle Scholar
  • 19 Lecointre L, Sananes N, Weingertner A , et al. Fetoscopic laser coagulation for twin-twin transfusion syndrome before 17 weeks' gestation: laser data, complications and neonatal outcomes. Ultrasound Obstet Gynecol 2014;
    PubMedGoogle Scholar
  • 20 Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371 (9606) 75-84
    CrossrefPubMedGoogle Scholar
  • 21 Ehsanipoor RM, Arora N, Lagrew DC, Wing DA, Chung JH. Twin versus singleton pregnancies complicated by preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2012; 25 (6) 658-661
    CrossrefPubMedGoogle Scholar
  • 22 Aziz N, Cheng YW, Caughey AB. Factors and outcomes associated with longer latency in preterm premature rupture of membranes. J Matern Fetal Neonatal Med 2008; 21 (11) 821-825
    CrossrefPubMedGoogle Scholar
  • 23 Sueters M, Middeldorp JM, Lopriore E, Oepkes D, Kanhai HH, Vandenbussche FP. Timely diagnosis of twin-to-twin transfusion syndrome in monochorionic twin pregnancies by biweekly sonography combined with patient instruction to report onset of symptoms. Ultrasound Obstet Gynecol 2006; 28 (5) 659-664
    CrossrefPubMedGoogle Scholar
  • 24 Yamamoto R, Ishii K, Muto H , et al. The use of amniotic fluid discordance in the early second trimester to predict severe twin-twin transfusion syndrome. Fetal Diagn Ther 2013; 34 (1) 8-12
    CrossrefPubMedGoogle Scholar
  • 25 Sueters M, Middeldorp JM, Oepkes D, Lopriore E, Vandenbussche FP. Twin-to-twin transfusion syndrome at 11 weeks of gestation. Am J Obstet Gynecol 2005; 193 (3 Pt 1) 887-888
    CrossrefPubMedGoogle Scholar
  • 26 Valsky DV, Eixarch E, Martinez-Crespo JM , et al. Fetoscopic laser surgery for twin-to-twin transfusion syndrome after 26 weeks of gestation. Fetal Diagn Ther 2012; 31 (1) 30-34
    CrossrefPubMedGoogle Scholar
  • 27 Murata M, Ishii K, Taguchi T , et al. The prevalence and clinical features of twin-twin transfusion syndrome with onset during the third trimester. J Perinat Med 2014; 42 (1) 93-98
    PubMedGoogle Scholar
  • 28 Van Mieghem T, Martin AM, Weber R , et al. Fetal cardiac function in recipient twins undergoing fetoscopic laser ablation of placental anastomoses for Stage IV twin-twin transfusion syndrome. Ultrasound Obstet Gynecol 2013; 42 (1) 64-69
    CrossrefPubMedGoogle Scholar
  • 29 Van Mieghem T, Klaritsch P, Doné E , et al. Assessment of fetal cardiac function before and after therapy for twin-to-twin transfusion syndrome. Am J Obstet Gynecol 2009; 200 (4) e1-e7
    PubMedGoogle Scholar
  • 30 Barrea C, Hornberger LK, Alkazaleh F , et al. Impact of selective laser ablation of placental anastomoses on the cardiovascular pathology of the recipient twin in severe twin-twin transfusion syndrome. Am J Obstet Gynecol 2006; 195 (5) 1388-1395
    CrossrefPubMedGoogle Scholar
  • 31 Rodeck CH, Weisz B, Peebles DM, Jauniaux E. Hypothesis: the placental 'steal' phenomenon - a possible hazard of amnioreduction. Fetal Diagn Ther 2006; 21 (3) 302-306
    CrossrefPubMedGoogle Scholar
  • 32 Fichera A, Ambrosi C, Taddei F, Gasparotti R, Frusca T. Severe brain damage from twin-twin transfusion syndrome treated with serial amnioreductions after 26 weeks: a case to reconsider the gestational age limits of laser therapy. Fetal Diagn Ther 2009; 25 (2) 203-205
    CrossrefPubMedGoogle Scholar
  • 33 Middeldorp JM, Lopriore E, Sueters M , et al. Twin-to-twin transfusion syndrome after 26 weeks of gestation: is there a role for fetoscopic laser surgery?. BJOG 2007; 114 (6) 694-698
    CrossrefPubMedGoogle Scholar
  • 34 Huang HR, Tsay PK, Chiang MC, Lien R, Chou YH. Prognostic factors and clinical features in liveborn neonates with hydrops fetalis. Am J Perinatol 2007; 24 (1) 33-38
    Article in Thieme ConnectPubMedGoogle Scholar
  • 35 Ville Y, Hecher K, Gagnon A, Sebire N, Hyett J, Nicolaides K. Endoscopic laser coagulation in the management of severe twin-to-twin transfusion syndrome. Br J Obstet Gynaecol 1998; 105 (4) 446-453
    CrossrefPubMedGoogle Scholar
  • 36 Kuller JA, Norton ME. Expanding the gestational age limits for laser treatment for twin-twin transfusion. Am J Obstet Gynecol 2013; 208 (3) 165-166
    CrossrefPubMedGoogle Scholar